Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
- PMID: 12039445
- DOI: 10.1016/s0047-6374(01)00366-9
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
Abstract
Receptor for Advanced Glycation Endproducts (RAGE) is a multiligand member of the immunoglobulin superfamily of cell surface molecules with a diverse repertoire of ligands. These ligands include products of nonenzymatic glycation, the Advanced Glycation Endproducts (AGEs, enriched in the diabetic milieu), members of the S100/calgranulin family of proinflammatory mediators, beta-sheet fibrillar structures (characteristic of amyloid) and amphoterin (present at high levels in the tumor bed). Ligation of RAGE by its ligands upregulates expression of the receptor and triggers an ascending spiral of cellular perturbation due to sustained RAGE-mediated cellular activation. For example, in the setting of diabetes, a vascular environment rich in AGEs and S100/calgranulins accelerates atherogenesis in murine models, and this can be blocked by intercepting the interaction of ligands with RAGE. While RAGE is certainly not the cause of diabetes, it functions as a progression factor driving cellular dysfunction underlying the development of diabetic complications as the microenvironment becomes enriched in its ligands. Though further studies will be required to determine the importance of RAGE-mediated cellular activation to human chronic diseases, it represents a novel receptor-ligand system potentially impacting on a range of pathophysiologic conditions.
Similar articles
-
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.Adv Drug Deliv Rev. 2002 Dec 7;54(12):1615-25. doi: 10.1016/s0169-409x(02)00160-6. Adv Drug Deliv Rev. 2002. PMID: 12453678 Review.
-
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489. Circ Res. 1999. PMID: 10082470 Review.
-
The biology of the receptor for advanced glycation end products and its ligands.Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. doi: 10.1016/s0167-4889(00)00087-2. Biochim Biophys Acta. 2000. PMID: 11108954 Review.
-
Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.Front Biosci. 2001 Oct 1;6:D1151-60. doi: 10.2741/schmidt. Front Biosci. 2001. PMID: 11578972 Review.
-
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.Arch Biochem Biophys. 2003 Nov 1;419(1):80-8. doi: 10.1016/j.abb.2003.08.030. Arch Biochem Biophys. 2003. PMID: 14568011 Review.
Cited by
-
Differential effects of glycation on protein aggregation and amyloid formation.Front Mol Biosci. 2014 Sep 2;1:9. doi: 10.3389/fmolb.2014.00009. eCollection 2014. Front Mol Biosci. 2014. PMID: 25988150 Free PMC article. Review.
-
Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice.Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1432-8. doi: 10.1161/ATVBAHA.108.167205. Epub 2008 May 15. Arterioscler Thromb Vasc Biol. 2008. PMID: 18483403 Free PMC article.
-
Diabetes-induced mechanophysiological changes in the small intestine and colon.World J Diabetes. 2017 Jun 15;8(6):249-269. doi: 10.4239/wjd.v8.i6.249. World J Diabetes. 2017. PMID: 28694926 Free PMC article. Review.
-
Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: role of the cardiac fibroblast.J Cardiovasc Transl Res. 2012 Dec;5(6):805-13. doi: 10.1007/s12265-012-9405-4. Epub 2012 Sep 29. J Cardiovasc Transl Res. 2012. PMID: 23054657 Review.
-
Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus.World J Gastroenterol. 2006 May 14;12(18):2846-57. doi: 10.3748/wjg.v12.i18.2846. World J Gastroenterol. 2006. PMID: 16718808 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical